According to Geron's latest financial reports and stock price the company's current number of shares outstanding is 594,977,503. At the end of 2023 the company had 594,977,503 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.59 B | 45.78% |
2022 | 0.40 B | 23.37% |
2021 | 0.33 B | 3.77% |
2020 | 0.31 B | 60.65% |
2019 | 0.19 B | 6.49% |
2018 | 0.18 B | 16.95% |
2017 | 0.15 B | 0.12% |
2016 | 0.15 B | 0.49% |
2015 | 0.15 B | 0.78% |
2014 | 0.15 B |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Gilead Sciences GILD | 1,248,000,000 | 109.76% | ๐บ๐ธ USA |
Incyte INCY | 224,078,000 | -62.34% | ๐บ๐ธ USA |
CTI BioPharma
CTIC | 131,566,000 | -77.89% | ๐บ๐ธ USA |
Bio-Techne TECH | 157,533,000 | -73.52% | ๐บ๐ธ USA |
Eterna Therapeutics ERNA | 5,410,000 | -99.09% | ๐บ๐ธ USA |